Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $29.50

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have earned a consensus recommendation of “Hold” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $29.50.

Several equities analysts have commented on the stock. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research lowered their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Needham & Company LLC dropped their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Robert W. Baird reduced their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research note on Friday, November 8th.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the stock. First Eagle Investment Management LLC grew its position in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after buying an additional 3,283,965 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares in the last quarter. Cooke & Bieler LP lifted its holdings in shares of DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Invenomic Capital Management LP bought a new position in DENTSPLY SIRONA during the 3rd quarter valued at $23,724,000. Finally, National Bank of Canada FI boosted its holdings in DENTSPLY SIRONA by 684.6% during the second quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock worth $21,586,000 after purchasing an additional 764,700 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 4.0 %

DENTSPLY SIRONA stock opened at $19.52 on Thursday. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a 50 day moving average of $23.25 and a 200-day moving average of $25.05. The stock has a market capitalization of $3.88 billion, a PE ratio of -9.44, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the prior year, the firm posted $0.49 EPS. The business’s revenue was up .4% on a year-over-year basis. On average, equities research analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.